Liver cancer combo: Proven treatment option for patients
Liver cancer combo shows promise as HLB seeks FDA approval for new treatment. Discover the latest updates on this innovative therapy.
Korea
Korea strategy: Proven insights from Ildong’s PEP approvals
Korea strategy is crucial as Ildong weighs options following Xocova’s PEP approvals in the US and Europe.